AP 24534, 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide
Ponatinib is a potent multi-target inhibitor of Abl, PDGFRalpha, VEGFR2, FGFR1 and Src with IC50 values of 0.37, 1.1, 1.5, 2.2 and 5.4 nM respectively.